Facility Open as of May 1st, 2009 in TEDA Tianjin, China
TEDA Tianjin, China, May 20 /PRNewswire/ -- Asymchem Laboratories, Inc., a leading research-based contract manufacturer of API's and intermediates, and Drug Products to the pharmaceutical industry, is pleased to announce the opening if its high potency Active Pharmaceutical Ingredient (API) and Drug Product facility in TEDA Tianjin, China.
This dedicated facility is sited at Asymchem's TEDA Tianjin 1 location, and provides state-of-the art containment for production of potent API's, as well as tablet and capsule manufacturing that incorporate potent ingredients. The new facility allows Asymchem to operate two separate API manufacturing trains of 50 and 100L, as well as additional facilities for smaller-scale research and production and oral dosage form manufacturing.
"We are pleased to expand our capabilities in process research and manufacturing into the potent compound arena, and provide our partners with cost-effective and quality-driven means for undertaking this type of work in China," states Dr. Hao Hong, CEO of Asymchem.
Asymchem seeks to be a leader among Chinese-located manufacturing operations not only in facility design but also worker safety, and the Tianjin potent compound site was designed and validated by recognized and accredited experts in the potent compound community. As one of the largest and most respected pharmaceutical manufacturers in China, Asymchem is pleased to extend its broad range of API and drug product capabilities to this exciting and rapidly emerging field of drug research and development.
Asymchem Laboratories is a leading research-based contract manufacturer specialized in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API's and Drug Products serving the pharmaceutical industry. With a 14-yr track record, Asymchem is committed to the highest level of quality and excellence in the integrated CMC services arena. For further information, please visit the Asymchem website at www.asymchem.com.
|SOURCE Asymchem Laboratories|
Copyright©2009 PR Newswire.
All rights reserved